课题基金 / 基金详情

项目摘要

项目成果

Laurie J. Ozelius的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): ABSTRACT Primary torsion dystonias (PTD) are a group of movement disorders characterized by twisting muscle contractures, where dystonia is the only clinical sign and there is no evidence of neuronal degeneration or an acquired cause. There are eight PTD loci assigned (DYT1, 2, 4, 6, 7, 13, 17 and 21), but only two of the genes (TOR1A-DYT1 and THAP1-DYT6) have been isolated. Apparent locus heterogeneity, reduced penetrance and significant phenotypic overlap between different forms of PTD limit the success of positional cloning approaches for dystonia gene discovery. New second generation sequencing technologies combined with whole exome capture libraries have revolutionized our ability to identify disease-causing mutations. Exome sequencing is based on capturing all exons of an individual's genome and sequencing them to an average 30X depth of coverage. We propose to apply exome sequencing to discover causative mutations in four multi- generation dystonia families. We will identify coding changes shared by a group of affected individuals in each family. These changes will be further tested for co-segregation with the disease in the remaining family members. The identified genes will be confirmed by screening for additional mutations in a collection of phenotypically similar small PTD families. Finally, in order to define the phenotypic spectrum associated with mutations, each gene will be examined in a large cohort of singleton PTD cases. The proposed research will lead to the identification of novel PTD genes and pathogenic mutations thus providing a key to understanding the molecular pathophysiology of the disease and the foundation for devising new therapeutic interventions.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/s11910-013-0410-z
发表时间: 2013-12
期刊: CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
影响因子: 5.6
作者: [Fuchs, Tania, Ozelius, Laurie J.]
通讯作者: Ozelius, Laurie J.
Dissecting Oligogenic Biomarkers in Ashkenazi Jews with Parkinson Disease
Dissecting Oligogenic Biomarkers in Ashkenazi Jews with Parkinson Disease
Dissecting Oligogenic Biomarkers in Ashkenazi Jews with Parkinson Disease
Dissecting Oligogenic Biomarkers in Ashkenazi Jews with Parkinson Disease
海外基金